Imperial Innovations Group Share News (IVO)

AIM WINNERS & LOSERS: In The Style shares shredded by profit warning

AIM WINNERS & LOSERS: In The Style shares shredded by profit warning

Imperial Innovations completes quick-change to Touchstone

(ShareCast News) - Imperial Innovations Group announced on Thursday that, further to the shareholder approval received at its AGM on 21 November 2016, the change of the company's name to Touchstone Innovations took effect on 4 January. The AIM-traded firm added that, with effect from 0800 GMT on Thu

Imperial Innovations to change name to 'Touchstone'

(ShareCast News) - Imperial Innovations Group announced on Friday that at its annual general meeting on 21 November, it will be seeking shareholder approval to change the name of the company to Touchstone Innovations. The AIM-traded group was originally formed as the technology transfer office for I

Imperial Innovations celebrates investment momentum

(ShareCast News) - Imperial Innovations Group noted on Monday that its portfolio company, Veryan Medical, has completed enrolment into the MIMICS-2 clinical study of its BioMimics 3D Self-Expanding Stent System. The AIM-traded firm said the MIMICS-2 study is a prospective, multicentre, interventiona

Imperial Innovations Says Veryan Completes Clinical Study Enrolment

Imperial Innovations' increases investments as pre-tax loss widens

(ShareCast News) - Imperial Innovations' annual pre-tax loss widened while the technology commercialisation and investment company increased investments across its business with universities and a joint venture. For the year ended 31 July, the pre-tax loss widened to £63.1m from £15.1m, last year, w

Imperial Innovations shares up on portfolio company progress

(ShareCast News) - Imperial Innovations Group updated the market on Thursday, noting that its portfolio company TopiVert Pharma has announced that the first patients have been dosed in its Phase IIa proof-of-concept study to evaluate the safety, tolerability and efficacy of a rectal formulation of T

Imperial Innovations: Topivert Moves To Phase Two Of TOP1288 Study

Imperial Innovations sells Permasense portfolio business

(ShareCast News) - AIM-listed Imperial Innovations has sold its portfolio company Permasense to Fortune 500 company Emerson Electric for an initial consideration of £30.6m in cash. Further amounts of up to £10m may be paid in addition, subject to the Permasense business achieving certain performance

Imperial Innovations invests £5.1m in new biotech start-up

(ShareCast News) - AIM-listed technology investor Imperial Innovations invested £5.1m in Artios Pharma, a new biotech start-up launched on Wednesday. Imperial Innovations contributed £5.1m to the £25m series A funding round, giving it a 14.9% interest in the new Cambridge- based company. Artios, wh

Cambridge University innovation investor raises 75 million pounds

LONDON, Aug 19 (Reuters) - Cambridge Innovation Capital, which commercializes technology and healthcare research from Cambridge University, has raised 75 million pounds ($98 million) from investors, including for the first time Woodford Investment Management. CIC, founded in 2013, has alrea

Imperial Innovations Notes Cell Medica Acquisition Of Delenex

Imperial Innovations Takes Part In New Funding For Econic Technologies

Imperial Innovations Says PsiOxus Signs Deal With Bristol-Myers Squibb